Topic

Cigna

A collection of 125 issues

Renewing Gattex (Teduglutide) Approval with Cigna in New Jersey: Complete Guide to Documentation and Deadlines

Quick Answer: Cigna requires specific renewal documentation for Gattex (teduglutide) including proof of reduced parenteral nutrition needs, lab results from the past 6 months (bilirubin, alkaline phosphatase, lipase, amylase), and colonoscopy documentation if you've been on therapy for over a year. Contact Accredo specialty pharmacy 2 weeks before

How to Get Emgality (Galcanezumab) Approved by Cigna in Illinois: Complete Timeline & Appeals Guide

Answer Box: Getting Emgality Approved by Cigna in Illinois Cigna requires prior authorization for Emgality (galcanezumab) with documented failure of both topiramate and a beta blocker before approval. Standard PA decisions take 7 business days, expedited reviews 72 hours. Illinois law requires internal appeals within 30 days and external review

How to Get Daybue (Trofinetide) Covered by Cigna in New Jersey: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Daybue Covered by Cigna in New Jersey Daybue (trofinetide) requires prior authorization from Cigna with specific documentation for Rett syndrome patients ≥2 years old. Your fastest path to approval: (1) Have your neurologist submit PA with confirmed MECP2 genetic testing and Clinical Severity Scale scores, (2) coordinate

Myths vs. Facts: Getting Zolgensma Covered by Cigna in Pennsylvania (Complete Appeals Guide)

Answer Box: Getting Zolgensma Covered by Cigna in Pennsylvania Myth: If your doctor prescribes Zolgensma, Cigna automatically covers it. Fact: Prior authorization is mandatory, requiring genetic confirmation, anti-AAV9 antibody testing ≤1:50, and certified site-of-care documentation. In Pennsylvania, if denied, you have strong appeal rights—the state's external

How to Renew Epidiolex (Cannabidiol) Approval with Cigna in Florida: 2024 Requirements and Timeline

Answer Box: Renewing Epidiolex Approval with Cigna in Florida Cigna requires annual prior authorization renewal for Epidiolex in Florida, typically 30-60 days before your current approval expires. Your neurologist must submit documentation showing continued clinical benefit (≥30-50% seizure reduction from baseline), current diagnosis confirmation, and hepatic monitoring results. Cigna renders

How to Get Juxtapid (lomitapide) Covered by Cigna in Ohio: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Juxtapid (lomitapide) Covered by Cigna in Ohio Juxtapid requires prior authorization from Cigna and is only covered for homozygous familial hypercholesterolemia (HoFH). Your fastest path to approval: (1) Confirm HoFH diagnosis with genetic/clinical documentation, (2) Document failure or intolerance to PCSK9 inhibitors like Repatha, and (3)

How to Get Darzalex Covered by Cigna in New York: Appeal Templates, Timelines & Prior Authorization Guide

Answer Box: Getting Darzalex Covered by Cigna in New York If Cigna denies Darzalex (daratumumab) coverage, you can appeal within 180 days. Most denials stem from insufficient prior therapy documentation or missing age verification (≥18 required). Quick action steps: 1) Call Cigna at 1-800-882-4462 for clarification, 2) Gather complete treatment

How to Get Strensiq (asfotase alfa) Covered by Cigna in Illinois: Decision Tree, Appeals, and Next Steps

Answer Box: Your Path to Strensiq Coverage in Illinois Cigna requires strict prior authorization for Strensiq (asfotase alfa) for pediatric-onset hypophosphatasia (HPP). You qualify if you have documented perinatal, infantile, or juvenile-onset HPP with low alkaline phosphatase and genetic confirmation. Next steps: (1) Gather diagnostic proof including ALPL mutation testing,

Getting Hetlioz LQ (Tasimelteon) Covered by Cigna in Michigan: Complete PA Guide and Appeals Process

Answer Box: How to Get Hetlioz LQ Covered by Cigna in Michigan Fastest path to approval: Submit prior authorization with confirmed Smith-Magenis Syndrome genetic testing, documented melatonin failure, and weight-based dosing rationale. If denied, file internal appeal within 180 days, then external review with Michigan DIFS within 127 days. Start

How to Get Mycapssa (Octreotide Oral) Covered by Cigna in Texas: PA Forms, Appeals & Success Tips

Answer Box: Getting Mycapssa Covered by Cigna in Texas Mycapssa (oral octreotide) requires prior authorization from Cigna with specific documentation: acromegaly diagnosis, prior response to injectable octreotide/lanreotide for 3+ months, and endocrinologist prescription. Fastest path: Have your endocrinologist submit PA with baseline IGF-1 labs, treatment history, and medical necessity